ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2943

Relationship Between  Menstruation and Symptoms of Behcet’s Syndrome

Gul Guzelant1, Yesim Ozguler2, Sinem Nihal Esatoglu3, Guzin Karatemiz2, Huri Ozdogan2, Sebahattin Yurdakul1, Hasan Yazici1 and Emire Seyahi1, 1Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Division of Rheumatology, Istanbul, Turkey, 3Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Behcet's syndrome and patient questionnaires

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Vasculitis - Poster III: Rarer Vasculitides

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: It is well known that menstruation triggers several conditions such as migraine, recurrent aphtous stomatitis and acne vulgaris in otherwise healthy individuals (1). It may exacerbate chronic autoimmune diseases and familial Mediterranean fever (FMF) (2-4). There is also one study that briefly mentions menstruation causes activation in Behçet’s syndrome (BS) (4). We investigated the relationship between menstruation and specifically the skin-mucosa lesions of BS. As controls, we studied FMF patients.

Methods: Premenopausal women with BS and FMF seen consecutively at the outpatient clinic of Cerrahpasa Medical Faculty at Istanbul, were interviewed. BS patients were asked whether they experienced increased skin-mucosa lesions during the menstrual period. A similar questionnaire assessing this time the frequency of serositis and fever attacks was given to the patients with FMF. As a control the participants were also asked whether they experienced headaches during the same period as well.

Results:  A total of 140 BS patients with a mean age of 36±8 and mean disease duration of 9±6 years were studied. While 21 (15 %) were off treatment, 103 (74 %) were using colchicine and the remaining were using other immunosuppressive agents. As shown in the Table, among BS patients, 78 (56 %) associated at least one symptom with menstruation. The most commonly reported symptom related with menstruation was the papulopustular involvement (50 %), followed by oral (30 %) and genital ulcers (21 %) and nodular lesions (21 %). We also studied 185 patients with FMF. Their mean age was 32±8 and mean disease duration was 12±8 years. All patients were using colchicine for a mean duration of 8±7 years. A total of 138 patients (75 %) reported that their attacks overlapped with menstruation. These attacks included mostly peritonitis in 126 patients (68 %), pleuritis in 102 (55 %), and fever in 73 (40 %). Among both BS and FMF patients, similar number of patients (41 % and 41 %, respectively) reported that menstruation triggered headaches.

Yes No do not remember
Behçet syndrome (n= 140)
Oral ulcer, n (%) 42 (30) 45 (32) 53 (38)
Genital ulcer, n (%) 30 (21) 94 (67) 16 (11)
Papulopustular lesions, n (%) 70 (50) 56 (40) 14 (10)
Nodular lesions, n (%) 30 (21) 90 (64) 20 (14)
At least one BS symptom, n (%) 78 (56) – –
Headache, n (%) 58 (41) 45 (33) 37 (26)
Familial Mediterranean Fever (n=185)
Peritonitis, n (%) 126 (68) 51 (28) 8 (4)
Pleuritis, n (%) 102 (55) 74 (40) 9 (5)
Fever, n (%) 73 (39) 100 (54) 12 (6)
At least one FMF symptom, n (%) 138 (75) – –
Headache, n (%) 76 (41) 77 (42) 32 (17)

Conclusion: This survey showed that, in about half of the patients with BS at least one skin mucosa lesion is exacerbated with menstruation. Most commonly reported were the papulopustular lesions. Menstruation had a stronger effect on FMF, triggering at least one symptom in about ¾ patients. The main limitation of the study was the self-reported assessment methodology, rather than a prospective diary assessment. Our findings provide further evidence that papulopustular lesions of BS and acne vulgaris are pathologically related (5).


Disclosure: G. Guzelant, None; Y. Ozguler, None; S. N. Esatoglu, None; G. Karatemiz, None; H. Ozdogan, None; S. Yurdakul, None; H. Yazici, None; E. Seyahi, None.

To cite this abstract in AMA style:

Guzelant G, Ozguler Y, Esatoglu SN, Karatemiz G, Ozdogan H, Yurdakul S, Yazici H, Seyahi E. Relationship Between  Menstruation and Symptoms of Behcet’s Syndrome [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/relationship-between-menstruation-and-symptoms-of-behcets-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relationship-between-menstruation-and-symptoms-of-behcets-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology